San diego: Led by Vice Minister of Health for Planning and Development Eng. Abdulaziz Al-Rumaih, the Saudi delegation is participating in the BIO International Convention 2026, being held in San Diego, United States, from June 22 to 25, through an integrated national pavilion showcasing the Kingdom's experience in health innovation and biotechnology. The participation aims to attract high-value investments and strategic partnerships that contribute to the development of the healthcare sector, in line with the objectives of the Health Sector Transformation Program under Saudi Vision 2030 and the National Biotechnology Strategy.
According to Saudi Press Agency, the pavilion includes 24 participating entities, comprising government organizations that support the biotechnology sector, major private-sector companies specializing in pharmaceuticals, biotechnology, business solutions, and investment funds, in addition to a number of national companies operating in the sector.
The participation featured a specialized roundtable attended by 25 global companies, as well as more than 30 introductory sessions and bilateral meetings with industry leaders. Discussions focused on the Kingdom's attractiveness for clinical trials, recent regulatory developments, and research infrastructure, in addition to the signing of several agreements and partnerships in pharmaceutical development and research collaboration. The program also included visits to leading international organizations in the sector to exchange expertise and transfer knowledge.
The Kingdom will host the BIO Middle East Conference from December 14 to 16, reflecting its growing position as a regional hub for biotechnology innovation that supports health innovation, research, and development.